
Last Posted: May 19, 2022
- Advancing Pharmacogenomics from Single-Gene to Preemptive Testing.
Haidar Cyrine E et al. Annual review of genomics and human genetics 2022 - An Interactive Pharmacogenetics Lesson Using PharmGKB To Individualize Pharmacotherapy Recommendations.
Mosquera Andrea et al. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2022 36 Suppl 1 - Using genomics to improve drug prescribing
L Blackburn, PHG Foundation, April 2022 - Sub-Analysis of CYP-GUIDES Data: Assessing the Prevalence and Impact of Drug-Gene Interactions in an Ethnically Diverse Cohort of Depressed Individuals.
Crutchley Rustin D et al. Frontiers in pharmacology 2022 13884213 - The Efficacy of a Didactic and Case-Based Pharmacogenomics Education Program on Improving the Knowledge and Confidence of Alberta Pharmacists.
Hayashi Meagan et al. Pharmacogenomics and personalized medicine 2022 15409-427 - Pharmacogenomics in clinical practice to prevent risperidone-induced hyperprolactinemia in autism spectrum disorder.
Biswas Mohitosh et al. Pharmacogenomics 2022 - Patients' perspectives of a pharmacist-provided clinical pharmacogenomics service.
Martin James L et al. Pharmacogenomics 2022 - Analyzing Precision Medicine Utilization with Real-World Data: A Scoping Review.
Douglas Michael P et al. Journal of personalized medicine 2022 12(4) - Ethnic Diversity and Warfarin Pharmacogenomics.
Asiimwe Innocent G et al. Frontiers in pharmacology 2022 13866058 - Real-world economic evaluation of prospective rapid whole-genome sequencing compared to a matched retrospective cohort of critically ill pediatric patients in the United States.
Diaby Vakaramoko et al. The pharmacogenomics journal 2022
More
Search Result Summary
- CDC Information (8)
- NIH Information (5)
- CDC Publications (2)
- COVID-19 (32)
- Human Genome Epidemiologic Studies (1978)
- GWAS Studies (84)
- Human Genomics Translation/Implementation Studies (484)
- Genomic Tests Evidence Synthesis (127)
- Genomic Tests Guidelines (39)
- Tier-Classified Guidelines (16)
- Non-Genomics Precision Health (5)
- Pathogen Advanced Molecular Detection (3)
- State Public Health Genomics Programs (2)
- Ethical/Legal and Social Issues (ELSI) (17)
Quick Links to Other Resources
Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2021
- Page last updated:May 24, 2022
- Content source: